My Quote Request
No products added yet
6505-01-548-5139
20 Products
TYLENOL 8 HOUR
ACETAMINOPHEN,EXTEN
NSN, MFG P/N
6505015485139
NSN
6505-01-548-5139
MFG
MCNEIL-PPC INC DBA MCNEIL CONSUMER HEALTH PRODUCTS DIVISION DIV MCNEIL PEDIATRICS A DIVISION OF MCNEIL PPC INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETAMINOPHEN EXTENDED RELEASE TABS 650MG BT 100S
SPECIAL FEATURES: ACETAMINOPHEN SA, 650MG, 100 TABLETS PER BOTTLE; TO BE USED FOR USOCCOM OPERAATORS KIT PILL PACK
Related Searches:
NDC49348-0704-10
ACETAMINOPHEN,EXTEN
NSN, MFG P/N
6505015485139
NSN
6505-01-548-5139
MFG
PERRIGO COMPANY DIV PERRIGO SOURCING SOLUTIONS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETAMINOPHEN EXTENDED RELEASE TABS 650MG BT 100S
SPECIAL FEATURES: ACETAMINOPHEN SA, 650MG, 100 TABLETS PER BOTTLE; TO BE USED FOR USOCCOM OPERAATORS KIT PILL PACK
Related Searches:
NDC50580-0297-10
ACETAMINOPHEN,EXTEN
NSN, MFG P/N
6505015485139
NSN
6505-01-548-5139
MFG
MCNEIL-PPC INC DBA MCNEIL CONSUMER HEALTH PRODUCTS DIVISION DIV MCNEIL PEDIATRICS A DIVISION OF MCNEIL PPC INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETAMINOPHEN EXTENDED RELEASE TABS 650MG BT 100S
SPECIAL FEATURES: ACETAMINOPHEN SA, 650MG, 100 TABLETS PER BOTTLE; TO BE USED FOR USOCCOM OPERAATORS KIT PILL PACK
Related Searches:
AVANDAMET
ROSIGLITAZON MALEAT
NSN, MFG P/N
6505015488399
NSN
6505-01-548-8399
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
SPECIAL FEATURES: AVANDAMET 2MG/500MG; CONTAINS 2 ORAL ANTIHYPERGLYCEMIC DRUGS; MANAGES TYPE 2 DIABETES; INCREASES INSULIN SENSITIVITY; BOTTLE OF 60
Related Searches:
NDC 0007-3167-18
ROSIGLITAZON MALEAT
NSN, MFG P/N
6505015488399
NSN
6505-01-548-8399
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
SPECIAL FEATURES: AVANDAMET 2MG/500MG; CONTAINS 2 ORAL ANTIHYPERGLYCEMIC DRUGS; MANAGES TYPE 2 DIABETES; INCREASES INSULIN SENSITIVITY; BOTTLE OF 60
Related Searches:
NDC 0023-9163-32
CYCLOSPORINE
NSN, MFG P/N
6505015488413
NSN
6505-01-548-8413
MFG
ALLERGAN INC
Description
SPECIAL FEATURES: 32X0.4 ML FLAKON; USED FOR TREATMENT OF KEROLOCONJUCTIVITIS (DRY EYE); CYCLOSPORINE OPHTHALMIC EMULSION
Related Searches:
RESTASIS OPHTALMIC
CYCLOSPORINE
NSN, MFG P/N
6505015488413
NSN
6505-01-548-8413
MFG
ALLERGAN INC
Description
SPECIAL FEATURES: 32X0.4 ML FLAKON; USED FOR TREATMENT OF KEROLOCONJUCTIVITIS (DRY EYE); CYCLOSPORINE OPHTHALMIC EMULSION
Related Searches:
3035
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505015489943
NSN
6505-01-548-9943
3035
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505015489943
NSN
6505-01-548-9943
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLILITERS BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: NERVE BLOCK
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPIVACAINE HCL INJ FOR ANESTHESIA 0.5% 10ML VIALS 5S
III SUPPLEMENTARY FEATURES: FOR CEC (CONTRACT EXTINGENCY CONTRACT)
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITHOUT PRESERVATIVE; FOR ANESTHESIA PURPOSES; PKG 5 SINGLE DOSE VIALS
TOTAL PRIMARY CONTAINER QUANTITY: 5
Related Searches:
BUPIVACAINE HCL
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505015489943
NSN
6505-01-548-9943
BUPIVACAINE HCL
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505015489943
NSN
6505-01-548-9943
MFG
APP PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLILITERS BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: NERVE BLOCK
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPIVACAINE HCL INJ FOR ANESTHESIA 0.5% 10ML VIALS 5S
III SUPPLEMENTARY FEATURES: FOR CEC (CONTRACT EXTINGENCY CONTRACT)
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITHOUT PRESERVATIVE; FOR ANESTHESIA PURPOSES; PKG 5 SINGLE DOSE VIALS
TOTAL PRIMARY CONTAINER QUANTITY: 5
Related Searches:
NDC00186-1033-12
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505015489943
NSN
6505-01-548-9943
NDC00186-1033-12
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505015489943
NSN
6505-01-548-9943
MFG
APP PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 MILLILITERS BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: NERVE BLOCK
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPIVACAINE HCL INJ FOR ANESTHESIA 0.5% 10ML VIALS 5S
III SUPPLEMENTARY FEATURES: FOR CEC (CONTRACT EXTINGENCY CONTRACT)
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITHOUT PRESERVATIVE; FOR ANESTHESIA PURPOSES; PKG 5 SINGLE DOSE VIALS
TOTAL PRIMARY CONTAINER QUANTITY: 5
Related Searches:
3036
VANCOMYCIN HYDROCHL
NSN, MFG P/N
6505015489957
NSN
6505-01-548-9957
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VANCOMYCIN HYDROCHLORIDE INJECTION,USP 500MG VIAL 25S
SPECIAL FEATURES: 500MG VIAL; 25 VIALS/PKG; ANTIBIOTIC; TO TREAT OR PREVENT INFECTIONS CAUSED BY BACTERIA
Related Searches:
NDC63323-0221-10
VANCOMYCIN HYDROCHL
NSN, MFG P/N
6505015489957
NSN
6505-01-548-9957
MFG
APP PHARMACEUTICALS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VANCOMYCIN HYDROCHLORIDE INJECTION,USP 500MG VIAL 25S
SPECIAL FEATURES: 500MG VIAL; 25 VIALS/PKG; ANTIBIOTIC; TO TREAT OR PREVENT INFECTIONS CAUSED BY BACTERIA
Related Searches:
VANCOMYCIN INJ
VANCOMYCIN HYDROCHL
NSN, MFG P/N
6505015489957
NSN
6505-01-548-9957
MFG
APP PHARMACEUTICALS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VANCOMYCIN HYDROCHLORIDE INJECTION,USP 500MG VIAL 25S
SPECIAL FEATURES: 500MG VIAL; 25 VIALS/PKG; ANTIBIOTIC; TO TREAT OR PREVENT INFECTIONS CAUSED BY BACTERIA
Related Searches:
2331
LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505015493510
NSN
6505-01-549-3510
2331
LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505015493510
NSN
6505-01-549-3510
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT AND 0.020 MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVONORGESTREL AND ETHINYL ESTRODIOL 28 TABLETS PER CYCLE, 6 CYCLE PER PKG 168 TABS
PRIMARY CONTAINER CONTENT QUANTITY: 168.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: ACTIVE INGREDIENTS: 0.1 MG OF LEVONORGESTREL; 0.02 MG ETHINYL ESTRADOIL; 28 TABLETS PER CYCLE, 6 CYCLES PER PKG; 168 TABLETS PER PKG; ORAL CONTRACEPTIVE
Related Searches:
6505NCM071353
LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505015493510
NSN
6505-01-549-3510
6505NCM071353
LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505015493510
NSN
6505-01-549-3510
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT AND 0.020 MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVONORGESTREL AND ETHINYL ESTRODIOL 28 TABLETS PER CYCLE, 6 CYCLE PER PKG 168 TABS
PRIMARY CONTAINER CONTENT QUANTITY: 168.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: ACTIVE INGREDIENTS: 0.1 MG OF LEVONORGESTREL; 0.02 MG ETHINYL ESTRADOIL; 28 TABLETS PER CYCLE, 6 CYCLES PER PKG; 168 TABLETS PER PKG; ORAL CONTRACEPTIVE
Related Searches:
NDC00555-9045-58
LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505015493510
NSN
6505-01-549-3510
NDC00555-9045-58
LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505015493510
NSN
6505-01-549-3510
MFG
BARR PHARMACEUTICALS LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT AND 0.020 MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVONORGESTREL AND ETHINYL ESTRODIOL 28 TABLETS PER CYCLE, 6 CYCLE PER PKG 168 TABS
PRIMARY CONTAINER CONTENT QUANTITY: 168.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: ACTIVE INGREDIENTS: 0.1 MG OF LEVONORGESTREL; 0.02 MG ETHINYL ESTRADOIL; 28 TABLETS PER CYCLE, 6 CYCLES PER PKG; 168 TABLETS PER PKG; ORAL CONTRACEPTIVE
Related Searches:
NDC52544-0967-28
LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505015493510
NSN
6505-01-549-3510
NDC52544-0967-28
LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505015493510
NSN
6505-01-549-3510
MFG
WATSON PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT AND 0.020 MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVONORGESTREL AND ETHINYL ESTRODIOL 28 TABLETS PER CYCLE, 6 CYCLE PER PKG 168 TABS
PRIMARY CONTAINER CONTENT QUANTITY: 168.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: ACTIVE INGREDIENTS: 0.1 MG OF LEVONORGESTREL; 0.02 MG ETHINYL ESTRADOIL; 28 TABLETS PER CYCLE, 6 CYCLES PER PKG; 168 TABLETS PER PKG; ORAL CONTRACEPTIVE
Related Searches:
SRONYX
LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505015493510
NSN
6505-01-549-3510
SRONYX
LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS,USP
NSN, MFG P/N
6505015493510
NSN
6505-01-549-3510
MFG
WATSON PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT AND 0.020 MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVONORGESTREL AND ETHINYL ESTRODIOL 28 TABLETS PER CYCLE, 6 CYCLE PER PKG 168 TABS
PRIMARY CONTAINER CONTENT QUANTITY: 168.000 TABLETS
PRIMARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: ACTIVE INGREDIENTS: 0.1 MG OF LEVONORGESTREL; 0.02 MG ETHINYL ESTRADOIL; 28 TABLETS PER CYCLE, 6 CYCLES PER PKG; 168 TABLETS PER PKG; ORAL CONTRACEPTIVE
Related Searches:
F1635-500ML
FORMALDEHYDE SOLUTION,USP
NSN, MFG P/N
6505015494414
NSN
6505-01-549-4414
F1635-500ML
FORMALDEHYDE SOLUTION,USP
NSN, MFG P/N
6505015494414
NSN
6505-01-549-4414
MFG
SIGMA-ALDRICH CORPORATION
Description
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
SPECIAL FEATURES: HCHO MOLECULAR FORMULA; 30.03 MOLECULAR WEIGHT; 1.03 VAPOR DENSITY; 52MM HG (37 DEG C) VAPORT PRESSURE; 572 DEG F AUTOIGNITION TEMPERATURE; 37WT PCI IN WATER CONCENTRATION; 10-15 PCT METHYL ALCOHOLE IMPURITIES; 96 DEG C BOILING POINT
Related Searches:
2287
FIBRIN SEALANT KIT
NSN, MFG P/N
6505015494689
NSN
6505-01-549-4689
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACCESSORY COMPONENTS AND QUANTITY: CONTAINS 4 SEPARATE VIALS: SEALER PROTEIN CONCENTRATE (HUMAN) VAPOR HEATED FREEZE DRIED, 1EA; FIBRINOLYSIS INHIBITOR SOLUTION (BOVINE), 1EA; THROMBIN (HUMAN) VAPOR HEATED, 1EA; FREEZE DRIED AND CALCIUM CHLORIDE SOLUTION, 1EA
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FIBRIN SEALANT KT TISSELL 1ML
SPECIAL FEATURES: 1 ML, 2 COMPONENT FIBRIN SEALANT VAPOR HEATED KIT, CONTAINS 4 SEPARATE VIALS; REQUIRES REFRIGERATION BTWN 2-8 DEG.C; DO NOT FREEZE; TOPICAL ADMINISTRATION ONLY
